Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Wang J, Sanmamed MF, Datar I, Su TT, Ji L, Sun J, Chen L, Chen Y, Zhu G, Yin W, Zheng L, Zhou T, Badri T, Yao S, Zhu S, Boto A, Sznol M, Melero I, Vignali DAA, Schalper K, Chen L.
Cell. 2019 Jan 10;176(1-2):334-347.e12. doi: 10.1016/j.cell.2018.11.010. Epub 2018 Dec 20.
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM
Zhu Y, Yao S, Augustine MM, Xu H, Wang J, Sun J, Broadwater M, Ruff W, Luo L, Zhu G, Tamada K, Chen L.
Sci Adv. 2016 Apr 8;2(4):e1500637. doi: 10.1126/sciadv.1500637. eCollection 2016 Apr.
B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets
Luo L, Zhu G, Xu H, Yao S, Zhou G, Zhu Y, Tamada K, Huang L, Flies AD, Broadwater M, Ruff W, van Deursen JM, Melero I, Zhu Z, Chen L.
PLoS One. 2015 Jun 11;10(6):e0130126. doi: 10.1371/journal.pone.0130126. eCollection 2015.
B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease
Deng R, Cassady K, Li X, Yao S, Zhang M, Racine J, Lin J, Chen L, Zeng D.
J Immunol. 2015 Jan 15;194(2):560-74. doi: 10.4049/jimmunol.1402157. Epub 2014 Dec 8.
PD-1 as an immune modulatory receptor
Cancer J. Jul-Aug 2014;20(4):262-4. doi: 10.1097/PPO.0000000000000060.
Advances in targeting cell surface signalling molecules for immune modulation
Yao S, Zhu Y, Chen L.
Nat Rev Drug Discov. 2013 Feb;12(2):130-46. doi: 10.1038/nrd3877.
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody
Lipson EJ, Sharfman WH, Drake CG, Wollner I, Taube JM, Anders RA, Xu H, Yao S, Pons A, Chen L, Pardoll DM, Brahmer JR, Topalian SL.
Clin Cancer Res. 2013 Jan 15;19(2):462-8. doi: 10.1158/1078-0432.CCR-12-2625. Epub 2012 Nov 20.